Native Toxins and Antigens for Diagnostics Development
Native Toxins and Antigens
for Diagnostics Development
Authentic Post-Translational Modifications for Optimal Antigenicity
Native antigens are widely used for immunodiagnostic assays such as ELISA and cytotoxicity testing. Enzo Life Sciences offers a broad range of native bacterial and viral antigens that deliver optimal antigenicity for use in vaccine therapeutics, serology-based diagnostic assays, and more.
Higher specificity and sensitivity
Minimal lot-to-lot variation
Reproducible scale-up for bulk quantities
Lyophilized format for extended shelf-life
Zika Virus
The Zika Virus is a member of the virus family Flaviviridae and is spread through Acedes mosquitoes. In 2015 the virus was categorized as an epidemic by the World Health Organization (WHO) as it spread through Brazil and the Americas. The virus causes symptoms such as fever and rash , it can also cause birth defects in women who are pregnant. Research continues as scientist work to develop a vaccine to prevent the spread of Zika virus.
Tick-borne Encephalitis:
First isolated in 1937, TBE is also a member of the virus family Flaviviridae common in Europe and far Eastern countries. Spreading through hard ticks that act as a vector and reservoir for TBEV, symptoms include fever, headaches, muscle aches, or vomiting. Through a vaccine is available in some areas (not available in the US), research continues to develop one as this affects over 12,000 people a year in Europe alone (according to the WHO).
From Clostridium difficile, strain VPI10463. Inactivated by formaldehyde., ≥95% (SDS-PAGE), ELISA, Antibody capture, Cytotoxicity studies, Immunogen, LINE assay | Print as PDF
From Clostridium difficile, strain VPI10463. Inactivated by formaldehyde., ≥95% (SDS-PAGE), ELISA, Antibody capture, Cytotoxicity studies, Immunogen, LINE assay | Print as PDF
Dengue virus NS1 protein serotype 1 presented in its native folded state with all post-translational modifications to deliver optimal antigenicity.
Produced in HEK 293 cells. Dengue Viral NS1 Serotype 1 (DENV1-NS1) from strain Nauru/Western Pacific/1974., ≥95% (SDS-PAGE), ELISA, Antibody capture, LINE assay, Vaccine research | Print as PDF
Dengue virus NS1 protein serotype 2 presented in its native folded state with all post-translational modifications to deliver optimal antigenicity.
Produced in HEK 293 cells. Dengue Viral NS1 Serotype 2 (DENV2-NS1) from strain Thailand/16681/84., ≥95% (SDS-PAGE), ELISA, Antibody capture, LINE assay, Vaccine research | Print as PDF
Dengue virus NS1 protein serotype 3 presented in its native folded state with all post-translational modifications to deliver optimal antigenicity.
Produced in HEK 293 cells. Dengue Viral NS1 Serotype 3 (DENV1-NS1) from strain Sri Lanka D3/H/IMTSSA-SRI/2000/1266., ≥95% (SDS-PAGE), ELISA, Antibody capture, LINE assay, Vaccine research | Print as PDF
Dengue virus NS1 protein serotype 4 presented in its native folded state with all post-translational modifications to deliver optimal antigenicity.
Produced in HEK 293 cells. Dengue Viral NS1 Serotype 4 (DENV4-NS1) from strain Dengue virus 4 Dominica/8146 69/1981., ≥95% (SDS-PAGE), ELISA, Antibody capture, LINE assay, Vaccine research | Print as PDF
Yellow Fever virus NS1 protein presented in its native folded state with all post-translational modifications to deliver optimal antigenicity.
Produced in HEK 293 cells. Yellow Fever Virus NS1 protein from strain 17D., ≥95% (SDS-PAGE), ELISA, Antibody capture, LINE assay, POC diagnostic, Vaccine research | Print as PDF
Bacterial lysate ideal for use as a broad positive control
From Neisseria gonorrhoeae, strain ATCC 19424. Inactivated by 3 hours at 56°C., ≥99%, ELISA, Antibody capture, Cytotoxicity studies, Immunogen, LINE assay | Print as PDF
Cell lysate ideal for use as a broad positive control
From Trichomonas vaginalis, strain C-1:NIH. Inactivated by freezing/thawing in water., ≥99%, ELISA, Antibody capture, Cytotoxicity studies, Immunogen, LINE assay | Print as PDF
Produced in HEK293 cells. Tick-borne encephalitis virus envelope protein is fused at the C-terminus to a mouse Fc-tag., ELISA, Antibody capture, LINE assay, Vaccine research | Print as PDF
Produced in HEK293 cells. Tick-borne encephalitis virus NS1 protein is fused at the C-terminus to a His-tag., ≥90% (SDS-PAGE), ELISA, Antibody capture, LINE assay, Vaccine research | Print as PDF
Produced in HEK293 mammalian cells. Recombinant Zika virus envelope protein with C-terminal 6-His tag., ≥95% (SDS-PAGE), ELISA, Antibody capture, LINE assay, Vaccine research | Print as PDF
Produced in mammalian HEK293 cells. Recombinant Zika Virus (Suriname strain) NS1 protein, incorporating a C-terminal 6x His tag., ≥90% (SDS-PAGE), ELISA, Antibody capture, LINE assay, Vaccine research | Print as PDF
Produced in mammalian HEK293 cells. Recombinant Zika Virus (Uganda strain) NS1 protein, incorporating a C-terminal 6x His tag., ≥85% (SDS-PAGE), ELISA, Antibody capture, LINE assay, Vaccine research | Print as PDF
Produced in mammalian HEK293 cells. Recombinant Zika Virus NS1 protein, with C-terminal 6x His tags., ≥85% (SDS-PAGE), ELISA, Antibody capture, LINE assay, Vaccine research | Print as PDF
Produced in mammalian HEK293 cells. Recombinant Zika virus-like particles consisting of envelope, pre-membrane, and membrane protein., ≥95% (SDS-PAGE), ELISA, Antibody capture, LINE assay, Vaccine research | Print as PDF